(+) Neomenthol

(+) Neomenthol

SCHEMBL260049

CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TRPA1TRPM8

The experimentally established mechanism targets of (+) Neomenthol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TRPM8 known ✓ Q7Z2W7 5/20 1.00
TRPA1 known ✓ O75762 2/20 1.00
EPHX1 P07099 3/20 0.52
ALDH1A1 P00352 1/20 0.41
KCNA5 P22460 1/20 0.39
TRPV1 Q8NER1 3/20 0.38
LMNA P02545 1/20 0.36
OPRM1 P35372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
(+)-Menthol SCHEMBL10072505 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL15449169 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
Isomenthol SCHEMBL677675 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
Racementhol SCHEMBL521946 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL9968934 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL1709231 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL12646785 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL13059620 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
Menthol SCHEMBL20771511 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5
(+)-Menthol SCHEMBL2454317 1.00 TRPM8 (1.00) TRPM8TRPA1EPHX1ALDH1A1KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 522 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12635710-B2 Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions EASTMAN CHEMICAL COMPANY (US) 2026-05-26 US claimed
EP-4651713-A1 PLANT TREATMENT COMPOSITIONS COMPRISING CHITOSAN-COATED EMULSIONS Universität Münster (DE) 2025-11-26 EP claimed
US-20250325463-A1 COMPOSITIONS (III) SYMRISE AG (DE) 2025-10-23 US claimed
CN-119302445-A Nicotine solid atomization preparation with efficacy of clearing throat and relieving sore throat 深圳麦克韦尔科技有限公司 2025-01-14 CN claimed
EP-4472606-A1 COMPOSITIONS (III) Symrise AG (DE) 2024-12-11 EP claimed
US-20240358611-A1 COMPOSITIONS SYMRISE AG (DE) 2024-10-31 US claimed
CN-118787123-A Water-based electronic cigarette atomization preparation and preparation method and application thereof 思摩尔国际控股有限公司 2024-10-18 CN claimed
WO-2024212780-A1 WATER-BASED ELECTRONIC CIGARETTE ATOMIZATION FORMULATION, AND PREPARATION METHOD THEREFOR AND USE THEREOF 思摩尔国际控股有限公司 2024-10-17 WO claimed
EP-4142508-B1 MINT FLAVOR COMPOSITIONS PROCTER & GAMBLE (US) 2024-10-09 EP claimed
EP-4429465-A1 COMPOSITIONS COMPRISING TRPM8 AGONISTIC COOLING AGENTS Symrise AG (DE) 2024-09-18 EP claimed
US-8445037-B2 Volatile distillate by-product of mint oil that promotes absorption and/or bioavailability of compounds of bio-medical and nutritional interest A. M. TODD COMPANY (US) 2013-05-21 US claimed
EP-2459526-A1 ORGANIC-SULPHIDE COMPOSITION WITH MASKED ODOUR Arkema France (FR) 2012-06-06 EP claimed
EP-2459527-A1 SOLVENT COMPOSITION BASED ON AN OXIDE OF AN ORGANIC SULFIDE WITH MASKED ODOUR Arkema France (FR) 2012-06-06 EP claimed
WO-2011012820-A1 SOLVENT COMPOSITION BASED ON AN OXIDE OF AN ORGANIC SULFIDE WITH MASKED ODOUR ARKEMA FRANCE (FR) 2011-02-03 WO claimed
WO-2011012815-A1 ORGANIC-SULPHIDE COMPOSITION WITH MASKED ODOUR ARKEMA FRANCE (FR) 2011-02-03 WO claimed
US-20100197801-A1 Volatile Distillate By-Product of Mint Oil That Promotes Absorption and/or Bioavailability of Compounds of Bio-Medical and Nutritional Interest A. M. TODD COMPANY (US) 2010-08-05 US claimed
US-20100076080-A1 Synthesis of Cyclohexane Derivatives Useful as Sensates in Consumer Products THE PROCTER & GAMBLE COMPANY 2010-03-25 US claimed
US-5298238-A Carriers with peppermint oil and limonene, cineole, ocimene, terpinene, terpinolene and alcohols or esters WARNER-LAMBERT COMPANY (US) 1994-03-29 US claimed
WO-1993008792-A1 LIQUID ORAL COMPOSITIONS COMPRISING DETERPENATED AND FRACTIONATED FLAVOR OILS WARNER-LAMBERT COMPANY (US) 1993-05-13 WO claimed
US-3960970-A MESITYL OXIDE, POTASSIUM HYDROXIDE BASF AKTIENGESELLSCHAFT (DT) 1976-06-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240358611-A1 COMPOSITIONS AZI2, NISCH, CIP2A TRPM8 168/4885TRPA1 17/4885EPHX1 2269/4885
US-12635710-B2 Methods of using formaldehyde-free antimicrobial compositions in animal by-product compositions FABP2, FABP1, VIP TRPM8 4666/4885TRPA1 4347/4885EPHX1 3721/4885
US-20100076080-A1 Synthesis of Cyclohexane Derivatives Useful as Sensates in Consumer Products NISCH, TRPM4, TRPM8 TRPM8 3/4885TRPA1 10/4885EPHX1 528/4885
US-20250325463-A1 COMPOSITIONS (III) NISCH, TAS1R3, TAS2R3 TRPM8 171/4885TRPA1 4/4885EPHX1 3052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.